CCRF-CEM (MTAP−/−) and Molt4 (MTAP+/+) T-cell ALL cell lines were treated with 6-TG or PDX and evaluated for efficacy 72 h later. The gene discussed is MTAP; the disease is acute lymphoblastic leukemia.